Shares of pharmaceutical companies rallied up to 4% on Tuesday as investors expect that US President Donald Trump‘s executive order will have minimal impact on US generics. Dr Reddy’s shares were up around 4% while Granules, Glenmark, Lupin, Divi’s Lab, and Aurobindo Pharma were trading around 3% higher. Nifty Pharma index itself rose around 2% … Read more
Bangalore: HFS Research has released a report in collaboration with Indegene, elaborating how Generative AI (GenAI) can turbocharge lifesciences growth if choices are selective and deliberate. The report offers a comprehensive analysis and an executive playbook for lifesciences leaders aiming to harness the transformative potential of GenAI to drive growth and innovation in a competitive … Read more
The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price inflation followed by supply chain disruption. All these affected the margins of the companies deeply. Synopsis Indian pharmaceutical market flattened after the pandemic led to a massive upsurge … Read more
By Arun Balasubramanian, Managing Director India & SAARC, ServiceNow The global vaccination rollout is, unequivocally, one of the most daunting logistical challenges of our generation. For India, the inoculation drive – already well underway – represents one of the biggest challenges considering our population size and geographic spread. More than 40 million citizens have received … Read more
Cyber-attack campaigns originating from Russia, China, Korea, and the Middle East have been targeting pharmaceutical companies, among other organisations in India to steal Covid-19 vaccine research data, patient information, clinical trials data, supply chain and vaccine production information, Singapore-based security research firm Cyfirma has said. Apart from India, organisations in 12 other countries are also … Read more